CE Mark for Rapid Acute Kidney Injury Test
Genetic Engineering News
Astute Medical's NephroCheck™ test has received a CE mark for commercialization in Europe. The cartridge-based sandwich immunoassay test, run on the firm's Astute140™ Meter, quantitatively measures two validated urinary biomarkers as a risk ...
Astute Medical Launches European Sales of Nephrocheck AKI Risk Assessment ...GenomeWeb
Astute Medical annonce le lancement du test NephroCheck™NEWS.GNOM.ES (press release)

all 8 news articles »